Long-term sustained-released in situ gels of a water-insoluble drug amphotericin B for mycotic arthritis intra-articular administration: preparation, in vitro and in vivo evaluation

References

• Schaberg DR, Culver DH, Gaynes RP. Major trends in the microbial etiology of nosocomial infection. Am J Med 1991;16:72–5
   Google Scholar
• Azaceta G, Olave T, De Los Martires LD, et al. Successful lipid-complexed amphotericin B treatment of Candida arthritis in a lymphoma patient. Rev Rhum Engl Ed 1999;66:434–5
   PubMedGoogle Scholar
• Venkatachalam N, Natarajan K, Balaraman M, Praveen KS. Formulation and evaluation of quercetin polycaprolactone microspheres for the treatment of rheumatoid arthritis. J Pharm Sci 2011;100:195–205
   PubMed Web of Science ®Google Scholar
• Gupta S, Vyas SP. Development and characterization of amphotericin B bearing emulsomes for passive and active macrophage targeting. J Drug Target 2007;15:206–17
   PubMed Web of Science ®Google Scholar
• Kishor MW, Olena S, Michael R, et al. Assessing the antifungal activity, pharmacokinetics, and tissue distribution of amphotericin B following the administration of Abelcet® and AmBisome® in combination with caspofungin to rats infected with Aspergillus fumigatus. J Pharm Sci 2007;96:1737–47
   PubMed Web of Science ®Google Scholar
• Vakil R, Kwon GS. Effect of cholesterol on the release of amphotericin B from PEG-phospholipid micelles. Mol Pharm 2008;5:98–104
   PubMedGoogle Scholar
• Fady I, Pavel G, Olena S, et al. Pharmacokinetics and tissue distribution of amphotericin B following oral administration of three lipid-based formulations to rats. Drug Dev Ind Pharm 2013;39:1277–83
   PubMed Web of Science ®Google Scholar
• Rabkwan C, Timothy SW, Teerapol S. Physicochemical properties and antifungal activity of amphotericin b incorporated in cholesteryl carbonate esters. J Pharm Sci 2011;100:1727–35
   PubMed Web of Science ®Google Scholar
• Barwicz J, Dumont I, Ouellet C, Gruda I. Amphotericin B toxicity as related to the formation of oxidatively modified low-density lipoproteins. Biospectroscopy 1998;4:135–44
   PubMedGoogle Scholar
• Lemke A, Kiderlen AF, Kayser O. Amphotericin B. Appl Microbiol Biotechnol 2005;68:151–62
   PubMed Web of Science ®Google Scholar
• Manosroi A, Kongkaneramit L, Manosroi J. Characterization of amphotericin B liposome formulations. Drug Dev Ind Pharm 2004;30:535–43
   PubMed Web of Science ®Google Scholar
• Olena S, Karen B, Verica R, et al. Assessing the antifungal activity and toxicity profile of amphotericin B lipid complex (ABLC; Abelcet®) in combination with caspofungin in experimental systemic aspergillosis. J Pharm Sci 2004;93:1382–9
   PubMed Web of Science ®Google Scholar
• Torrado JJ, Espada R, Ballesteros MP, Torrado-Santiago S. Amphotericin B formulations and drug targeting. J Pharm Sci 2008;97:2405–25
   PubMed Web of Science ®Google Scholar
• Claus LJG, Susan WL, Henrik J, et al. Intra-articular depot formulation principles: role in the management of postoperative pain and arthritic disorders. J Pharm Sci 2008;97:4622–54
   PubMed Web of Science ®Google Scholar
• Alessia P, Francesca S, Giuseppe R, et al. Methylprednisolone-loaded PLGA microspheres: a new formulation for sustained release via intra-articular administration. A comparison study with methylprednisolone acetate in rats. J Pharm Sci 2011;100:4580–6
   PubMed Web of Science ®Google Scholar
• Fátima OC, Emma S, João JSS, Alberto CP. Drug release from lipid liquid crystalline phases: relation with phase behavior. Drug Dev Ind Pharm 2010;36:470–81
   PubMed Web of Science ®Google Scholar
• Engstrom S. Drug delivery from cubic and other lipid-water phases. Lipid Technol 1990;2:42–5
   Google Scholar
• Rizwan SB, Hanley T, Boyd BJ, et al. Liquid crystalline systems of phytantriol and glyceryl monooleate containing a hydrophilic protein: characterisation, swelling and release kinetics. J Pharm Sci 2009;98:4191–204
   PubMed Web of Science ®Google Scholar
• Shah JC, Sadhale Y, Chilukuri DM. Cubic phase gels as drug delivery systems. Adv Drug Deliv Rev 2001;47:229–50
   PubMed Web of Science ®Google Scholar
• Moustapha O, Rasmané S, Issa TS, et al. Monoolein–water liquid crystalline gels of gentamicin as bioresorbable implants for the local treatment of chronic osteomyelitis: in vitro characterization. Drug Dev Ind Pharm 2008;34:753–60
   PubMed Web of Science ®Google Scholar
• Nielsen LS, Schubert L, Hansen J. Bioadhesive drug delivery systems. I. Characterization of mucoadhesive properties of systems based on glyceryl monooleate and glyceryl monolinoleate. Eur J Pharm Sci 1998;6:231–9
   PubMed Web of Science ®Google Scholar
• Réeff J, Gaignaux A, Goole J, et al. Characterization and optimization of GMO-based gels with long term for intraarticular administration release. Int J Pharm 2013;45:95–103
   Google Scholar
• Michel M, Adorjan A. Quantitation of amphotericins by reverse-phase high-performance liquid chromatography. J Pharm Sci 1984;73:835–8
   PubMed Web of Science ®Google Scholar
• Kroschwitz JI. Polymers: polymer characterization and analysis. Rheol Meas 1990;63:7–725
   Google Scholar
• Burckbuchler V, Mekhlou G, Paillard Giteau A, et al. Rheological and syringeability properties of highly concentrated human polyclonal immunoglobulin solutions. Eur J Pharm Biopharm 2010;76:351–6
   PubMed Web of Science ®Google Scholar
• Linda SL, Wesley W, Helen MB. Pharmacokinetic study of methotrexate following intra-articular injection of methotrexate loaded poly(L-lactic acid) microspheres in rabbits. J Pharm Sci 2005;94:1204–15
   PubMed Web of Science ®Google Scholar
• Réeff J, Gaignaux A, Goole J, et al. New sustained-release intraarticular gel formulations based on monolein for local treatment of arthritic diseases. Drug Dev Ind Pharm 2013;39:1731–41
   PubMed Web of Science ®Google Scholar
• Adriana GQ, David QG, Pierre B. Monoolein: a review of the pharmaceutical applications. Drug Dev Ind Pharm 2000;26:809–20
   PubMed Web of Science ®Google Scholar
• Kazuhiro M, Kunihiko M, Hideyuki K, et al. Effects of low-viscosity sodium hyaluronate preparation on the pulmonary absorption of rh-insulin in rats. Drug Dev Ind Pharm 2001;27:365–71
   PubMed Web of Science ®Google Scholar
• Kelly RM, Meyer JD, Matsuura JE, et al. In vitro release kinetics of gentamycin from a sodium hyaluronate gel delivery system suitable for the treatment of peripheral vestibular disease. Drug Dev Ind Pharm 1999;25:15–20
   PubMed Web of Science ®Google Scholar
• Chen J, Leu Y, Fang C, et al. Thermosensitive hydrogels composed of hyaluronic acid and gelatin as carriers for the intravesical administration of cisplatin. J Pharm Sci 2011;100:655–66
   PubMed Web of Science ®Google Scholar
• Djamila A, Kamel A, Philippe P, Véronique A. Recent advances in ocular drug delivery. Drug Dev Ind Pharm 2013;39:1599–617
   PubMed Web of Science ®Google Scholar
• Dong J, Jiang D, Wang Z, et al. Intra-articular delivery of liposomal celecoxib–hyaluronate combination for the treatment of osteoarthritis in rabbit model. Int J Pharm 2013;441:285–90
   PubMed Web of Science ®Google Scholar
• Susan WL, Anna BF, Jesper G, et al. In vitro and in vivo characteristics of celecoxib in situ formed suspensions for intra-articular administration. J Pharm Sci 2011;100:4330–7
   PubMed Web of Science ®Google Scholar
• Ouedraogo M, Semdé R, Some IT, et al. Monooleine-water liquid crystalline gels of gentamicin as bioresorbable implants for the local treatment of chronic osteomyelitis: in vitro characterization. Drug Dev Ind Pharm 2008;34:753–60
   PubMed Web of Science ®Google Scholar
• Mitchell SA, Balwinski KM. A framework to investigate drug release variability arising from hypromellose viscosity specifications in controlled release matrix tablets. J Pharm Sci 2008;97:2277–85
   PubMed Web of Science ®Google Scholar
• Shah MH, Paradkar A. Effect of HLB of additives on the properties and drug release from the glyceryl monooleate matrices. Eur J Pharm Biopharm 2007;67:166–74
   PubMed Web of Science ®Google Scholar
• Saettone MF, Giannaccini B, Chetoni P, et al. Evaluation of high- and low-molecular-weight fractions of sodium hyaluronate and an ionic complex as adjuvants for topical ophthalmic vehicles containing pilocarpine. Int J Pharm 1991;72:131–9
   Google Scholar
• Fam H, Bryant JT, Kontopoulou M. Rheological properties of synovial fluids. Biorheology 2007;44:59–74
   PubMed Web of Science ®Google Scholar
• Mazzucco D, McKinley G, Scott RD, Spector M. Rheology of joint fluid in total knee arthroplasty patients. J Orthop Res 2002;20:1157–63
   PubMed Web of Science ®Google Scholar
• Brown TJ, Laurent UBG, Fraser JRE. Turnover of hyaluronan in synovial joints: elimination of labeled hyaluronan from the knee joint of the rabbit. Exp Physiol 1991;76:125–34
   PubMed Web of Science ®Google Scholar
• Scale D, Wobig M, Wolpert W. Viscosupplementation of osteoarthritic knees with hylan: a treatment schedule study. Curr Ther Res 1994;55:220–32
   Web of Science ®Google Scholar
• Balazs EA. The physical properties of synovial fluid and the special role of hyaluronic acid. In: Helfet A, ed. In disorders of the knee. Philadelphia: T.B. Lippincott Company; 1974:63–75
   Google Scholar